Benoı̂t Stijlemans

Camelid immunoglobulins and nanobody technology

Serge Muyldermans, Toya Nath Baral, V. Cortez Retamozzo et al. · Veterinary Immunology and Immunopathology · 2008 · 539 citations · Full text

Life Sciences, Biotechnology, Immunology +14

Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies

Benoı̂t Stijlemans, Katja Conrath, Virna Cortez‐Retamozo et al. · Journal of Biological Chemistry · 2004 · 275 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment

Eva Van Overmeire, Benoı̂t Stijlemans, Felix Heymann et al. · Cancer Research · 2015 · 233 citations

Life Sciences, Immunology, Oncology +17

Immunogenicity Risk Profile of Nanobodies

Chloé Ackaert, Natalia Smiejkowska, Catarina Xavier et al. · Frontiers in Immunology · 2021 · 218 citations · Full text

Pharmacy, Immunology, Oncology +17

1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism

Hannelie Korf, Mathias Wenes, Benoı̂t Stijlemans et al. · Immunobiology · 2012 · 185 citations · Full text

Life Sciences, Immunology, Pharmacology +17